Tirzepatide is a synthetic research peptide functioning as a dual agonist of the GIP and GLP-1 receptors, two incretin pathways widely studied for their roles in metabolic regulation.

It is frequently explored in research related to insulin signaling, glucagon modulation, energy balance, and gastrointestinal physiology. Its dual-pathway mechanism makes it a relevant compound in metabolic and endocrine studies.

This compound is provided as a lyophilized powder.